STALIF M FLX 3D-Printed ALIF Device Listed by SPINE Market Group as the Top ALIF 3D-printed Cage

February 11, 2021

STALIF M FLX platform represents the latest material advancement offered by Centinel Spine.

FLX implants are 3D-printed porous titanium, meticulously engineered down to the cellular unit level to mimic bone. The FLX family of implants boasts equivalent subsidence performance to PEEK; contains a proprietary, interconnected FUSE-THRU lattice with a structure similar to bone; and has an optimized mechanical environment to reduce stress shielding, enable fusion assessment, and support bony in-growth, on-growth, and thru-growth.

STALIF M FLX implants have been engineered based on the STALIF® design which has over 30 years of proven clinical history and has helped thousands of patients regain their lives—including the world’s winningest athlete, Tiger Woods. STALIF implants uniquely provide compressive fixation at the fusion site, pulling the vertebral bodies onto the implant and graft material to enhance opportunities for fusion in line with Wolff’s Law of Bone Healing.

Centinel Spine is proud that the STALIF M FLX device has been recognized as the top ALIF 3D-printed cage,” stated Centinel Spine CEO Steve Murray. “As a company, we remain dedicated to continued product quality, innovation, and furthering clinical evidence. STALIF M FLX is the latest evolution of the STALIF portfolio, and continues our heritage in advancing the stand-alone market founded over 30 years ago,” concluded Murray.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”